Socioeconomic disparities in the prevalence of comorbid chronic conditions among Canadian adults with cancer

References

• Ay C, Beyer-Westendorf J, Pabinger I. Treatment of cancer-associated1 venous thromboembolism in the age of direct oral anticoagulants. Ann Oncol. 2019;30(6):897–907.
   PubMed Web of Science ®Google Scholar
• Xie L, Semenciw R, Mery L. Cancer incidence in Canada: trends and projections (1983–2032). Health Promot Chronic Dis Prev Can. 2015;35 (Suppl 1):2–186.
   PubMedGoogle Scholar
• Poirier AE, Ruan Y, Walter SD, et al. The future burden of cancer in Canada: long-term cancer incidence projections 2013–2042. Cancer Epidemiol. 2019;59:199–207.
   PubMed Web of Science ®Google Scholar
• Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493–1505.
   PubMed Web of Science ®Google Scholar
• Bowker SL, Pohar SL, Johnson JA. A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer. Health Qual Life Outcomes. 2006;4(1):17.
   PubMed Web of Science ®Google Scholar
• Patel R, Liu WK, Patel HR, et al. Are health-care policies restricting further progress in cancer survival outcomes? Lancet Oncol. 2019;20(12):e657.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O. Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer. J Comp Eff Res. 2020;9(17):1233–1241.
   PubMed Web of Science ®Google Scholar
• Austin SR, Wong YN, Uzzo RG, et al. Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser Score work. Med Care. 2015;53(9):e65–e72.
   PubMed Web of Science ®Google Scholar
• Mehta HB, Sura SD, Adhikari D, et al. Adapting the Elixhauser comorbidity index for cancer patients. Cancer. 2018;124(9):2018–2025.
   PubMed Web of Science ®Google Scholar
• Canadian Community Health Survey – Annual component (CCHS). [cited 2020 Mar 12]. Available from: https://www.statcan.gc.ca/eng/survey/household/3226.
   Google Scholar
• Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans – TCPS 2. 2018 [cited 2020 Sep 23]. Available from: https://ethics.gc.ca/eng/policy-politique_tcps2-eptc2_2018.html.
   Google Scholar
• Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337–350.
   PubMed Web of Science ®Google Scholar
• Williams GR, Deal AM, Lund JL, et al. Patient-reported comorbidity and survival in older adults with cancer. Oncologist. 2018;23(4):433–439.
   PubMed Web of Science ®Google Scholar
• Hahn EE, Gould MK, Munoz-Plaza CE, et al. Understanding comorbidity profiles and their effect on treatment and survival in patients with colorectal cancer. J Natl Compr Canc Netw. 2018;16(1):23–34.
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Aisner DL, Wood DE, et al. NCCN guidelines insights: non-small cell lung cancer, version 5.2018. J Natl Compr Canc Netw. 2018;16(7):807–821.
   PubMed Web of Science ®Google Scholar
• Brenner DR, Weir HK, Demers AA, Canadian Cancer Statistics Advisory Committee, et al. Projected estimates of cancer in Canada in 2020. CMAJ. 2020;192(9):E199–E205.
   PubMed Web of Science ®Google Scholar
• Annual Demographic Estimates: Canada, Provinces and Territories. 2018 [cited 2021 Jan 3]. Available from: https://www150.statcan.gc.ca/n1/pub/91-215-x/2018002/sec2-eng.htm.
   Google Scholar
• Abdel-Rahman O, Salas AS, Watanabe SM, et al. Burden of depression among Canadian adults with cancer; results from a national survey. Expert Rev Pharmacoecon Outcomes Res. 2020;21:1–6.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O, Koski S, Mulder K. Real-world patterns of chemotherapy administration and attrition among patients with metastatic colorectal cancer. Int J Colorectal Dis. 2021;36(3):493–499.
   PubMed Web of Science ®Google Scholar
• Nelson SE, Wilson K. The mental health of indigenous peoples in Canada: a critical review of research. Soc Sci Med. 2017;176:93–112.
   PubMed Web of Science ®Google Scholar
• Hajizadeh M, Hu M, Bombay A, et al. Socioeconomic inequalities in health among indigenous peoples living off-reserve in Canada: trends and determinants. Health Policy. 2018;122(8):854–865.
   PubMed Web of Science ®Google Scholar
• Key Health Inequalities in Canada: A National Portrait – Executive Summary. [cited 2021 Mar 18]. Available from: https://www.canada.ca/en/public-health/services/publications/science-research-data/key-health-inequalities-canada-national-portrait-executive-summary.html.
   Google Scholar
• Abdel-Rahman O. Patterns and trends of cancer screening in Canada: results from a contemporary national survey. J Natl Compr Canc Netw. 2021;19(1):68–76.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O. Patient-reported cognitive and functional impairments among older Canadians with cancer: a population-based study. J Pain Symptom Manage. 2021;61(2):279–286.
   PubMed Web of Science ®Google Scholar
• Nishri ED, Sheppard AJ, Withrow DR, et al. Cancer survival among first nations people of Ontario, Canada (1968–2007). Int J Cancer. 2015;136(3):639–645.
   PubMed Web of Science ®Google Scholar
• McGahan CE, Linn K, Guno P, et al. Cancer in first nations people living in British Columbia, Canada: an analysis of incidence and survival from 1993 to 2010. Cancer Causes Control. 2017;28(10):1105–1116.
   PubMed Web of Science ®Google Scholar
• Ward BW, Schiller JS. Prevalence of multiple chronic conditions among US adults: estimates from the national health interview survey. Prev Chronic Dis. 2010;10:E65.
   Google Scholar
• Abdel-Rahman O. Impact of diabetes on the outcomes of patients with castration-resistant prostate cancer treated with docetaxel: a pooled analysis of three phase III studies. Clin Genitourin Cancer. 2019;17(1):e104–e112.
   PubMed Web of Science ®Google Scholar
• Ahmed SH, Moussa Sherif DE, Fouad Y, et al. Principles of a risk evaluation and mitigation strategy (REMS) for breast cancer patients receiving potentially cardiotoxic adjuvant treatments. Expert Opin Drug Saf. 2016;15(7):911–923.
   PubMed Web of Science ®Google Scholar
• Andersson Y, Bergkvist L, Frisell J, et al. Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer. Breast Cancer Res Treat. 2019;177(2):469–475.
   PubMed Web of Science ®Google Scholar
• Heng DY, Choueiri TK, Rini BI, et al. Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. Ann Oncol. 2014;25(1):149–154.
   PubMed Web of Science ®Google Scholar